Guideline adherence and long-term clinical outcomes in patients with acute myocardial infarction: a Japanese Registry of Acute Myocardial Infarction Diagnosed by Universal Definition (J-MINUET) substudy.


Journal

European heart journal. Acute cardiovascular care
ISSN: 2048-8734
Titre abrégé: Eur Heart J Acute Cardiovasc Care
Pays: England
ID NLM: 101591369

Informations de publication

Date de publication:
Dec 2020
Historique:
pubmed: 25 1 2020
medline: 1 6 2021
entrez: 25 1 2020
Statut: ppublish

Résumé

The association between guideline adherence and long-term outcomes in patients with acute myocardial infarction in real-world clinical practice remains unclear. We investigated 3283 consecutive patients with acute myocardial infarction who were selected from a prospective, nation-wide, multicentre registry (J-MINUET) database covering 28 institutions in Japan between July 2012 and March 2014. Among the 2757 eligible patients, we evaluated the use of seven guideline-recommended therapies, including urgent revascularisation, door-to-balloon time of 90 minutes or less, and five discharge medications (P2Y12 inhibitors on aspirin, beta-blockers, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, statins, lipid-lowering drugs). The primary endpoint was a composite of all-cause death, non-fatal myocardial infarction, non-fatal stroke, cardiac failure and urgent revascularisation for unstable angina up to 3 years. The overall median composite guideline adherence was 85.7%. Patients were divided into the following three groups: complete (100%) adherence group ( The use of guideline-based therapies for patients with acute myocardial infarction in contemporary clinical practice was associated with significant decreases in adverse long-term clinical outcomes. UMIN Unique trial Number: UMIN000010037.

Sections du résumé

BACKGROUND BACKGROUND
The association between guideline adherence and long-term outcomes in patients with acute myocardial infarction in real-world clinical practice remains unclear.
METHODS METHODS
We investigated 3283 consecutive patients with acute myocardial infarction who were selected from a prospective, nation-wide, multicentre registry (J-MINUET) database covering 28 institutions in Japan between July 2012 and March 2014. Among the 2757 eligible patients, we evaluated the use of seven guideline-recommended therapies, including urgent revascularisation, door-to-balloon time of 90 minutes or less, and five discharge medications (P2Y12 inhibitors on aspirin, beta-blockers, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, statins, lipid-lowering drugs). The primary endpoint was a composite of all-cause death, non-fatal myocardial infarction, non-fatal stroke, cardiac failure and urgent revascularisation for unstable angina up to 3 years.
RESULTS RESULTS
The overall median composite guideline adherence was 85.7%. Patients were divided into the following three groups: complete (100%) adherence group (
CONCLUSION CONCLUSIONS
The use of guideline-based therapies for patients with acute myocardial infarction in contemporary clinical practice was associated with significant decreases in adverse long-term clinical outcomes.
TRIAL REGISTRATION BACKGROUND
UMIN Unique trial Number: UMIN000010037.

Identifiants

pubmed: 31976749
doi: 10.1177/2048872620902024
doi:

Substances chimiques

Adrenergic beta-Antagonists 0
Hydroxymethylglutaryl-CoA Reductase Inhibitors 0
Platelet Aggregation Inhibitors 0
Aspirin R16CO5Y76E

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

939-947

Investigateurs

Tadaya Sato (T)
Hiroyuki Kyono (H)
Tetsuya Tobaru (T)
Takahito Sone (T)
Yasuhiro Sone (Y)
Masashi Fujino (M)
Kunihiko Nishimura (K)
Junichi Kotani (J)
Hiroyuki Okura (H)
Masaaki Uematsu (M)
Shirou Uemura (S)
Seiji Hokimoto (S)

Auteurs

Hideki Wada (H)

Department of Cardiovascular Medicine, Juntendo University Shizuoka Hospital, Japan.

Manabu Ogita (M)

Department of Cardiovascular Medicine, Juntendo University Shizuoka Hospital, Japan.

Satoru Suwa (S)

Department of Cardiovascular Medicine, Juntendo University Shizuoka Hospital, Japan.

Koichi Nakao (K)

Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center, Japan.

Yukio Ozaki (Y)

Department of Cardiology, Fujita Health University Hospital, Japan.

Kazuo Kimura (K)

Division of Cardiology, Yokohama City University Medical Center, Japan.

Junya Ako (J)

Department of Cardiovascular Medicine, Kitasato University, Japan.

Teruo Noguchi (T)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan.

Satoshi Yasuda (S)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan.

Kazuteru Fujimoto (K)

Department of Cardiology, National Hospital Organization Kumamoto Medical Center, Japan.

Yasuharu Nakama (Y)

Department of Cardiology, Hiroshima City Hospital, Japan.

Takashi Morita (T)

Division of Cardiology, Osaka General Medical Center, Japan.

Wataru Shimizu (W)

Department of Cardiovascular Medicine, Nippon Medical School, Japan.

Yoshihiko Saito (Y)

First Department of Internal Medicine, Nara Medical University, Japan.

Atsushi Hirohata (A)

Department of Cardiovascular Medicine, The Sakakibara Heart Institute of Okayama, Japan.

Yasuhiro Morita (Y)

Department of Cardiology, Ogaki Municipal Hospital, Japan.

Teruo Inoue (T)

Department of Cardiovascular Medicine, Dokkyo Medical University, Japan.

Atsunori Okamura (A)

Department of Cardiology, Sakurabashi Watanabe Hospital, Japan.

Toshiaki Mano (T)

Cardiovascular Center, Kansai Rosai Hospital, Japan.

Kazuhito Hirata (K)

Department of Cardiology, Okinawa Prefectural Chubu Hospital, Japan.

Kengo Tanabe (K)

Division of Cardiology, Mitsui Memorial Hospital, Japan.

Yoshisato Shibata (Y)

Department of Cardiology, Miyazaki Medical Association Hospital, Japan.

Mafumi Owa (M)

Department of Cardiovascular Medicine, Suwa Red Cross Hospital, Japan.

Kenichi Tsujita (K)

Department of Cardiovascular Medicine, Kumamoto University, Japan.

Hiroshi Funayama (H)

Department of Integrated Medicine, Saitama Medical Center Jichi Medical University, Japan.

Nobuaki Kokubu (N)

Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University, Japan.

Ken Kozuma (K)

Department of Cardiology, Teikyo University, Japan.

Shiro Uemura (S)

Department of Cardiology, Kawasaki Medical School, Japan.

Tetsuya Toubaru (T)

Department of Cardiology, Sakakibara Heart Institute, Japan.

Keijiro Saku (K)

Department of Cardiology, Fukuoka University School of Medicine, Japan.

Shigeru Oshima (S)

Department of Cardiology, Gunma Prefectural Cardiovascular Center, Japan.

Kunihiro Nishimura (K)

Department of Preventive Medicine and Epidemiologic Informatics, National Cerebral and Cardiovascular Center, Japan.

Yoshihiro Miyamoto (Y)

Department of Preventive Medicine and Epidemiologic Informatics, National Cerebral and Cardiovascular Center, Japan.

Hisao Ogawa (H)

Department of Preventive Medicine and Epidemiologic Informatics, National Cerebral and Cardiovascular Center, Japan.

Masaharu Ishihara (M)

Division of Coronary Artery Disease, Hyogo College of Medicine, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH